Litcius/Paper detail

Safety and immunogenicity of live, attenuated intranasal Bordetella pertussis vaccine (BPZE1) in healthy adults

C. Buddy Creech, Natalia Jimenez‐Truque, Naomi Kown, Katherine Sokolow, Eric Brady, Sandra Yoder, Ken Solovay, Keith Rubin, Stephanie Noviello, Elizabeth Hensel, Semhal Selamawi, Adetunji Bakare, Mat Makowski, Kristina T. Lu

2022Vaccine21 citationsDOI

Topics & Concepts

ReactogenicityImmunogenicityMedicineBordetella pertussisVaccinationImmunologyNasal administrationAdverse effectPertussis toxinPlaceboAntibodyInternal medicineBiologyG proteinPathologyGeneticsBacteriaAlternative medicineReceptorBacterial Infections and VaccinesPneumonia and Respiratory InfectionsInfectious Encephalopathies and Encephalitis
Safety and immunogenicity of live, attenuated intranasal Bordetella pertussis vaccine (BPZE1) in healthy adults | Litcius